Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;64(10):1223-1229.
doi: 10.1111/myc.13342. Epub 2021 Jul 4.

Proven COVID-19-associated pulmonary aspergillosis in patients with severe respiratory failure

Affiliations

Proven COVID-19-associated pulmonary aspergillosis in patients with severe respiratory failure

Francesco Fortarezza et al. Mycoses. 2021 Oct.

Abstract

Background: An increasing number of reports have described the COVID-19-associated pulmonary aspergillosis (CAPA) as being a further contributing factor to mortality. Based on a recent consensus statement supported by international medical mycology societies, it has been proposed to define CAPA as possible, probable, or proven on the basis of sample validity and thus diagnostic certainty. Considering current challenges associated with proven diagnoses, there is pressing need to study the epidemiology of proven CAPA.

Methods: We report the incidence of histologically diagnosed CAPA in a series of 45 consecutive COVID-19 laboratory-confirmed autopsies, performed at Padova University Hospital during the first and second wave of the pandemic. Clinical data, laboratory data and radiological features were also collected for each case.

Results: Proven CAPA was detected in 9 (20%) cases, mainly in the second wave of the pandemic (7/17 vs. 2/28 of the first wave). The population of CAPA patients consisted of seven males and two females, with a median age of 74 years. Seven patients were admitted to the intensive care unit. All patients had at least two comorbidities, and concomitant lung diseases were detected in three cases.

Conclusion: We found a high frequency of proven CAPA among patients with severe COVID-19 thus confirming at least in part the alarming epidemiological data of this important complication recently reported as probable CAPA.

Keywords: Aspergillus; CAPA; COVID-19; SARS-CoV-2; histology.

PubMed Disclaimer

Conflict of interest statement

All the authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
An index case of CAPA (patient 3, Table 1). Axial chest CT demonstrating typical COVID‐19 signs such as bilateral patchy ground glass opacities with interstitial thickening (A). Gross sample of the left lung. The cut surface shows several roundish haemorrhagic areas (B). At the panoramic view, the lung parenchyma appears edematous with multiples aggregates of fungal hyphae (C, haematoxylin and eosin stain, original magnification 20×). The fungal aggregate fill the alveolar space (arrow) and invade the arteriolar vessel with necrosis of the vascular wall (asterisks). Small aggregates of hyphae are also visible in the lumen (D, haematoxylin and eosin stain, original magnification 200×). At higher magnification, the hyphae show the typical morphological features (septation, diameter from 2.5 to 4.5 μm, dichotomous branching at 45 degrees angles) of the Aspergillus spp (E, haematoxylin and eosin stain, original magnification 400×)

References

    1. van Arkel ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, Verweij PE, Bentvelsen RG. COVID‐19 Associated pulmonary aspergillosis. Am J Respir Crit Care Med. 2020;63:528‐534. - PMC - PubMed
    1. Alanio A, Dellière S, Fodil S, Bretagne S, Mégarbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID‐19. Lancet Respir Med. 2020;8:e48‐e49. - PMC - PubMed
    1. Nasir N, Farooqi J, Mahmood SF, Jabeen K. COVID‐19‐associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID‐19 pneumonia: an observational study from Pakistan. Mycoses. 2020;63(8):766‐770. - PMC - PubMed
    1. Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID‐19‐associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020;21(6):e149‐e162. - PMC - PubMed
    1. Calabrese F, Pezzuto F, Fortarezza F, et al. Pulmonary pathology and COVID‐19: lessons from autopsy. The experience of european pulmonary pathologists. Virchows Arch. 2020;477:359‐372. - PMC - PubMed